AstraZeneca announces multibillion dollar investments in China as Big Pharma is increasingly looking east for innovation.

China’s stock market has long been more volatile than Beijing would like, a problem that has taken on greater urgency as the ...

In a year that surprised skeptics, China equities delivered strong performance in 2025, buoyed by improving corporate ...

Bridgewater Associates said it is still bullish on Chinese stocks this year, after the local market’s rally helped its ...

Reuters reported that China has approved sales of Nvidia's H200, sending the AI chip giant's shares higher in premarket trade ...

China's bold policy changes and booming tech sectors are creating fresh momentum for U.S.-listed Chinese companies like Tencent Holdings TCEHY, Bilibili BILI, and Baidu BIDU, as Beijing prepares for ...

"China remains dedicated to turning its vast market into one that benefits the whole world, expanding the pie of cooperation, ...

Nvidia shares fall 3.4% as $30B China chip deal awaits approval. AMD's weak China forecast adds pressure to AI sector.

China’s $1.2T 2025 trade surplus may fuel a stronger yuan in 2026, impacting S&P 500 pricing power. Click here to know more.

There is a good reason why Rivian is a better pick.